Bioavailability Enhancement
Our expert developed formulations for poor water-soluble drugs that increase bioavailability from 3% to 60%. The formulation was successfully filed for Phase I clinical studies. Having worked with poor water-soluble new drug substance for more than 20 years, our expert is experienced with different technologies to increase bioavailability. Our goal is to help you develop a product that is capable of manufacture and marketable. Some of the technologies that we are capable of working on are:
- Micronization that can go as small as submicron (non-particle technologies)
- Lipid based hard-shell and soft-shell capsules
- Emulsions and micro emulsion technologies
- Cyclodextrins complexation technologies
- Solid-solutions/Polymer-complex technologies (Hot-melt extrusion)
- Parental formulation for poor water-soluble drugs